deficiencia 1 514 1 9599,	
galactosemia) 1 514 1 9597,	
galactosa 2 514 2 9590,9594,	
glucosa 1 514 1 9587,	
malabsorción 2 514 2 9585,9588,	
isomaltasa 1 514 1 9580,	
déficit 2 514 2 9575,9578,	
contienen 1 514 1 9564,	
(hidroxi-metil-glutaril)-CoA 1 514 1 9213,	
presentar 1 514 1 8851,	
debería 1 514 1 8156,	
17 1 514 1 7957,	
recomendado 1 514 1 7925,	
confirmar 1 514 1 7915,	
formulaciones 1 514 1 7907,	
ó 1 514 1 7899,	
formulación 2 514 2 7875,7882,	
cambiados 1 514 1 7872,	
(n=167) 1 514 1 7542,	
proporcionaron 1 514 1 7533,	
partido 1 514 1 7106,	
masticado 1 514 1 7104,	
machacado 1 514 1 7103,	
haberse 1 514 1 7102,	
determinado 1 514 1 7095,	
" 1 514 1 6998,	
mg"" 1 514 1 6997,	
cara 1 514 1 6994,	
grabado 1 514 1 6991,	
lleva 1 514 1 6990,	
blanco 1 514 1 6988,	
color 1 514 1 6987,	
triangular 1 514 1 6985,	
Comprimido 1 514 1 6983,	
recubierto 2 514 2 6982,6984,	
recubiertos 1 514 1 6953,	
comprimidos 6 514 6 6952,7100,7519,7884,7913,9561,	
europa 1 514 1 6943,	
emea 1 514 1 6942,	
//www 1 514 1 6941,	
http 1 514 1 6940,	
Europea 1 514 1 6936,	
web 1 514 1 6932,	
página 1 514 1 6931,	
detallada 1 514 1 6923,	
TEXTO 1 514 1 6920,	
2006 1 514 1 6913,	
15 1 514 1 6909,	
revalidación 1 514 1 6908,	
última 1 514 1 6907,	
2001 1 514 1 6903,	
autorización 1 514 1 6898,	
Fecha 2 514 2 6895,6904,	
AUTORIZACIÓN/RENOVACIÓN 1 514 1 6891,	
PRIMERA 1 514 1 6890,	
FECHA 2 514 2 6887,6915,	
EU/1/01/171/001 1 514 1 6885,	
NÚMERO(S) 1 514 1 6880,	
Unido 1 514 1 6878,	
Maidenhead 1 514 1 6873,	
South 1 514 1 6871,	
Lane 1 514 1 6870,	
Ltd 1 514 1 6868,	
Europa 1 514 1 6867,	
	Wyeth 1 514 1 6866,	
COMERCIALIZACIÓN 2 514 2 6865,6884,	
AUTORIZACIÓN 3 514 3 6863,6882,6894,	
LA 4 514 4 6862,6889,6893,6917,	
ml) 1 514 1 6845,	
adicional 1 514 1 6841,	
recipiente 1 514 1 6837,	
Rellenar 1 514 1 6835,	
beber 2 514 2 6831,6855,	
vigorosamente 2 514 2 6829,6853,	
Agitar 1 514 1 6828,	
incluido 1 514 1 6823,	
líquidos 1 514 1 6822,	
vaso 1 514 1 6792,	
correcta 1 514 1 6784,	
Vaciar 1 514 1 6781,	
prescrita 1 514 1 6775,	
extraer 1 514 1 6772,	
dosificadora 1 514 1 6768,	
Instrucciones 1 514 1 6760,	
locales 1 514 1 6759,	
contacto 1 514 1 6749,	
hayan 1 514 1 6746,	
manipulaciones 1 514 1 6733,	
topacio 1 514 1 6710,	
vidrio 2 514 2 6709,6794,	
Botellas 1 514 1 6707,	
Naturaleza 1 514 1 6702,	
horas) 1 514 1 6699,	
corto 1 514 1 6694,	
botellas 1 514 1 6685,	
protegerlo 1 514 1 6673,	
original 1 514 1 6671,	
botella 2 514 2 6670,6780,	
8º 1 514 1 6665,	
C 2 514 2 6663,6691,	
2º 1 514 1 6662,	
(entre 1 514 1 6661,	
Conservar 2 514 2 6658,6667,	
conservación 1 514 1 6657,	
6) 1 514 1 6646,	
Taplow 1 514 1 6872,	
25º 2 514 2 6637,6690,	
sobrepasar 1 514 1 6635,	
ambiente 2 514 2 6632,6688,	
temperatura 2 514 2 6631,6687,	
(a 1 514 1 6630,	
dosificadoras 1 514 1 6627,	
abierto 1 514 1 6621,	
Frasco 1 514 1 6620,	
validez 1 514 1 6617,	
dilución 3 514 3 6605,6642,6817,	
plástico 3 514 3 6602,6724,6796,	
inmediatamente 2 514 2 6593,6651,	
instrucciones 1 514 1 6590,	
considerar 1 514 1 6588,	
importante 1 514 1 6587,	
vinilo 1 514 1 6581,	
Etilhexil)ftalato 1 514 1 6574,	
Precauciones 3 514 3 6552,6654,6727,	
diluido 1 514 1 6533,	
ascorbilo) 1 514 1 6525,	
palmitato 1 514 1 6523,	
soja 1 514 1 6521,	
grasos 1 514 1 6519,	
ácidos 1 514 1 6518,	
5%) 1 514 1 6517,	
5% 1 514 1 6514,	
etanol 1 514 1 6512,	
diglicéridos 1 514 1 6511,	
monoglicéridos 1 514 1 6510,	
propilenglicol 1 514 1 6509,	
PG 1 514 1 6507,	
Phosal 1 514 1 6505,	
80 2 514 2 6504,6564,	
Polisorbato 1 514 1 6503,	
Lista 1 514 1 6500,	
FARMACÉUTICOS 1 514 1 6497,	
Ver 2 514 2 6491,6551,	
esquelética) 1 514 1 6490,	
osificación 1 514 1 6489,	
retrasos 1 514 1 6485,	
fetos 1 514 1 6483,	
mortalidad 1 514 1 6476,	
manifestó 1 514 1 6474,	
embrio/fetotoxicidad 1 514 1 6471,	
provocó 1 514 1 6470,	
monos 1 514 1 6466,	
gigantes 1 514 1 6455,	
materiales 1 514 1 6744,	
atrofia 1 514 1 6451,	
histológicas 1 514 1 6448,	
espermatozoides 1 514 1 6436,	
recuentos 1 514 1 6434,	
parcialmente 1 514 1 6430,	
13 1 514 1 6425,	
macho 1 514 1 6418,	
reproducción 1 514 1 6408,	
importancia 1 514 1 6399,	
consideran 1 514 1 6397,	
normalmente 1 514 1 6395,	
luteinizante 1 514 1 6393,	
hormona 1 514 1 6392,	
especie 1 514 1 6386,	
dependiente 1 514 1 6383,	
indicativos 1 514 1 6379,	
probablemente 1 514 1 6377,	
testiculares 1 514 1 6376,	
intersticiales 1 514 1 6375,	
adenomas 1 514 1 6373,	
crónica 1 514 1 6369,	
relacionados 1 514 1 6365,	
lesiones 2 514 2 6357,6447,	
observados 1 514 1 6346,	
crónico 1 514 1 6339,	
secundarios 1 514 1 6335,	
(linfomas) 1 514 1 6334,	
esperarse 1 514 1 6332,	
conocido 1 514 1 6329,	
vasos 1 514 1 6799,	
Es 1 514 1 6328,	
hembra) 1 514 1 6327,	
granulocítica 1 514 1 6325,	
leucemia 1 514 1 6324,	
adenoma 1 514 1 6316,	
hembras) 1 514 1 6315,	
machos 1 514 1 6313,	
(ratones 3 514 3 6312,6320,6326,	
linfomas 1 514 1 6311,	
incidencias 1 514 1 6309,	
ratones 2 514 2 6301,6354,	
cabo 1 514 1 6299,	
llevados 1 514 1 6297,	
carcinogenicidad 1 514 1 6296,	
Estudios 1 514 1 6294,	
micronúcleos 1 514 1 6291,	
ratón 2 514 2 6283,6293,	
hámster 1 514 1 6269,	
ovario 1 514 1 6267,	
aberración 1 514 1 6262,	
bacterias 1 514 1 6255,	
inversa 1 514 1 6253,	
mutación 2 514 2 6252,6277,	
mutagénico 1 514 1 6248,	
pulmonar 1 514 1 6244,	
fosfolipidosis 1 514 1 6243,	
hematopoyesis 1 514 1 6240,	
cromosómica 1 514 1 6263,	
óseas 1 514 1 6239,	
callosidades 1 514 1 6238,	
tubular 2 514 2 6230,6452,	
degeneración 1 514 1 6229,	
islotes 1 514 1 6225,	
repercusión 1 514 1 6215,	
detectadas 1 514 1 6201,	
preclínicos 1 514 1 6189,	
Datos 1 514 1 6188,	
diálisis) 1 514 1 6185,	
(pacientes 1 514 1 6182,	
ausente 1 514 1 6181,	
varía 1 514 1 6177,	
semividaobservada 1 514 1 6148,	
67 1 514 1 6132,	
170 1 514 1 6121,	
43 1 514 1 6075,	
61 1 514 1 6071,	
ulceración 1 514 1 6234,	
t1/2 2 514 2 6066,6112,	
B) 1 514 1 6058,	
Child-Pugh 2 514 2 6055,6103,	
(Clasificación 2 514 2 6053,6101,	
moderada 1 514 1 6052,	
individuos 1 514 1 6038,	
adaptador 1 514 1 6717,	
gran 1 514 1 6034,	
mayores 2 514 2 6023,7529,	
ml/h/kg) 3 514 3 6018,6025,6031,	
(580 1 514 1 6017,	
menor 1 514 1 6015,	
peso 2 514 2 6008,6480,	
normalizado 1 514 1 6005,	
CL/F 2 514 2 6004,6082,	
50 2 514 2 5973,6506,	
- 1 514 1 5972,	
(con 2 514 2 5968,6484,	
respecto 1 514 1 5940,	
diluir 1 514 1 5934,	
agua 4 514 4 5932,6546,6810,6847,	
(AUC) 1 514 1 5910,	
(tmáx 1 514 1 5898,	
(Cmáx 1 514 1 5882,	
34 1 514 1 5872,	
produjo 1 514 1 5868,	
líquido 2 514 2 5865,6542,	
características 1 514 1 5860,	
observaron 2 514 2 6428,6438,	
alteró 1 514 1 5858,	
contenido 2 514 2 5855,6704,	
alimentación 1 514 1 5852,	
responderían 1 514 1 5805,	
pequeña 1 514 1 5779,	
excretó 1 514 1 5777,	
heces 1 514 1 5773,	
%) 2 514 2 5768,5783,	
(91 1 514 1 5766,	
recuperó 1 514 1 5762,	
[14C]sirolimus 1 514 1 5757,	
90 1 514 1 5745,	
constituye 1 514 1 5742,	
componente 1 514 1 5735,	
hidroxilo 1 514 1 5728,	
210 1 514 1 6117,	
principales 1 514 1 5726,	
siete 1 514 1 5724,	
identificaron 1 514 1 5723,	
hidroxilación 1 514 1 5718,	
O-desmetilación 1 514 1 5716,	
metaboliza 1 514 1 5713,	
IIIA 1 514 1 5705,	
diversas 1 514 1 6171,	
n=219) 1 514 1 5685,	
22 1 514 1 5677,	
grasa 1 514 1 5857,	
cromatográfico; 2 514 2 5660,5684,	
expresado 2 514 2 5655,5679,	
ng/mL 1 514 1 5654,	
LC-SM/SM) 1 514 1 5607,	
partir 2 514 2 5601,6577,	
calculados 1 514 1 5599,	
ml/h/kg 1 514 1 5597,	
72 1 514 1 5596,	
pediátricos 3 514 3 5964,6013,6022,	
182 1 514 1 5594,	
ng·h/ml 1 514 1 5592,	
70 1 514 1 5591,	
158 1 514 1 5589,	
AUCt 1 514 1 5587,	
ss 3 514 3 5572,5580,5588,	
III 3 514 3 5569,5644,6712,	
clínico 2 514 2 5566,6219,	
diarias 1 514 1 5556,	
Rapamune) 1 514 1 5550,	
(4 2 514 2 5546,5650,	
19 2 514 2 5537,9120,	
Cl/F 1 514 1 6128,	
farmacocinéticos 2 514 2 5532,6165,	
celulares 2 514 2 5526,6374,	
elementos 1 514 1 5525,	
ampliamente 2 514 2 5522,5714,	
distribuye 1 514 1 5521,	
(450 1 514 1 6024,	
alcanzaron 1 514 1 5501,	
medias 1 514 1 5495,	
corta 1 514 1 5491,	
embargo 1 514 1 5485,	
Sin 1 514 1 5484,	
h 2 514 2 5483,5586,	
16 1 514 1 5482,	
repetida 1 514 1 5452,	
14 3 514 3 5447,5672,6899,	
(Sandimmun) 1 514 1 5442,	
sistémica 1 514 1 5432,	
disponibilidad 1 514 1 5431,	
únicas 1 514 1 5415,	
hora 1 514 1 5408,	
pico 3 514 3 5405,5877,5897,	
daclizumab 1 514 1 5382,	
evitarse 1 514 1 5961,	
utilizó 1 514 1 5375,	
mejor 1 514 1 5355,	
numéricamente 1 514 1 5323,	
antagonista 2 514 2 5306,5341,	
(MMF) 1 514 1 5302,	
multicéntricos 1 514 1 5289,	
éste 1 514 1 5283,	
vio 1 514 1 5273,	
correspondiente 1 514 1 5243,	
convertidos 1 514 1 5236,	
normal 2 514 2 5221,6179,	
urinaria 1 514 1 5220,	
9%) 1 514 1 5202,	
melanóticas 1 514 1 5175,	
comparados 1 514 1 5134,	
continuó 2 514 2 5131,5192,	
orina 2 514 2 5122,5785,	
ratios 1 514 1 5119,	
dieron 1 514 1 5085,	
emergentes 1 514 1 5079,	
mejoró 1 514 1 5055,	
eventos 1 514 1 5034,	
<40 2 514 2 5026,5110,	
cuya 3 514 3 5023,5046,5107,	
estrato 3 514 3 5020,5043,5104,	
trasplante) 1 514 1 5001,	
evaluó 1 514 1 4974,	
mL/min) 1 514 1 4972,	
MMF 1 514 1 5337,	
(20-40 1 514 1 4968,	
fracturas 1 514 1 6236,	
inicio 1 514 1 4965,	
FG 6 514 6 4962,5024,5047,5108,5212,5223,	
aleatorizado 1 514 1 4953,	
Mediante 1 514 1 4950,	
retrasó 1 514 1 4948,	
suceso 1 514 1 4946,	
>40 3 514 3 4971,5049,5213,	
carcinoma 2 514 2 4937,6319,	
(8 2 514 2 4929,5674,	
continuaron 3 514 3 4909,5138,5247,	
cohorte 2 514 2 4905,4917,	
neoplasias 2 514 2 4896,5172,	
quitar 1 514 1 4879,	
sanguínea 1 514 1 4866,	
presión 1 514 1 4865,	
creciente 1 514 1 4850,	
análisis 1 514 1 4838,	
elevada 2 514 2 4811,4902,	
respectivamente) 2 514 2 4779,4934,	
8% 3 514 3 4775,4933,5199,	
(9 1 514 1 4774,	
pancreáticas 1 514 1 6228,	
comparado 2 514 2 4757,5187,	
biopsia 1 514 1 4748,	
confirmado 1 514 1 4746,	
primer 2 514 2 4741,4945,	
seguimiento) 1 514 1 4733,	
seguido 2 514 2 4710,4818,	
favor 1 514 1 4705,	
estadísticamente 1 514 1 4697,	
hubo 2 514 2 4694,5609,	
48 2 514 2 4692,4804,	
grupos 2 514 2 4689,4785,	
similar 1 514 1 4686,	
supervivencia 3 514 3 4679,4701,4854,	
recomiendan 1 514 1 4665,	
inadecuada 1 514 1 4630,	
micromoles/l 1 514 1 4623,	
>400 1 514 1 4622,	
""RAPAMUNE 1 514 1 6995,	
Banff 1 514 1 4610,	
Grado 1 514 1 4608,	
agudos 1 514 1 4606,	
episodios 1 514 1 4603,	
sobrevivieron 1 514 1 4584,	
anteriores 1 514 1 4583,	
injertos 1 514 1 4582,	
proteína/creatinina 1 514 1 5120,	
cuyos 1 514 1 4581,	
re-trasplante 1 514 1 4580,	
muerto 1 514 1 4574,	
donante 1 514 1 4571,	
aloinjerto 1 514 1 4567,	
incluyó 2 514 2 4562,5008,	
ciclosporina-mantenimiento 2 514 2 4558,4659,	
fase 3 514 3 4553,5568,5643,	
presentaron 1 514 1 4542,	
estudiaron 2 514 2 4539,4649,	
(S/P) 1 514 1 5514,	
Ensayos 1 514 1 4536,	
aloinjertos 2 514 2 4535,5423,	
mediadas 1 514 1 4525,	
suprimiendo 1 514 1 4523,	
B 1 514 1 4522,	
directo 1 514 1 4513,	
linfocitos 1 514 1 4500,	
neto 1 514 1 4491,	
resulta 1 514 1 4477,	
ciclo 1 514 1 4471,	
progresión 1 514 1 4469,	
crítica 1 514 1 4466,	
quinasa 1 514 1 4465,	
(mTOR) 1 514 1 4463,	
mamíferos 1 514 1 4462,	
Rapamicina 1 514 1 4460,	
Diana 1 514 1 4457,	
Molécula 1 514 1 4456,	
12-sirolimus 1 514 1 4450,	
FKPB 1 514 1 4449,	
complejo 1 514 1 4448,	
FKPB-12 1 514 1 4444,	
	"Comprimido 1 514 1 6981,	
une 1 514 1 4438,	
experimental 1 514 1 4433,	
di-(2- 1 514 1 6573,	
fertilidad 1 514 1 6415,	
± 5 514 5 5481,5575,5583,5590,5595,	
evidencia 1 514 1 4432,	
mecanismo 1 514 1 4420,	
demuestran 1 514 1 4412,	
Ciertos 1 514 1 4410,	
independientes 1 514 1 4407,	
dependientes 2 514 2 4405,4614,	
intracelulares 1 514 1 4404,	
señales 2 514 2 4403,4488,	
(mínimo 1 514 1 6842,	
transducción 2 514 2 4401,4486,	
citosólica 1 514 1 4442,	
estímulos 1 514 1 4395,	
inducida 1 514 1 4389,	
T 2 514 2 4388,4520,	
activación 4 514 4 4384,4453,4497,4516,	
A10 1 514 1 4380,	
ATC 1 514 1 4378,	
Código 1 514 1 4377,	
selectivos 1 514 1 4376,	
farmacoterapéutico 1 514 1 4373,	
Grupo 1 514 1 4372,	
farmacodinámicas 1 514 1 4371,	
conservar 1 514 1 6683,	
Propiedades 2 514 2 4370,5385,	
ESTE 1 514 1 4366,	
PROPIEDADES 1 514 1 4363,	
cantidad 4 514 4 4359,5780,6774,6783,	
dializable 1 514 1 4356,	
será 1 514 1 4355,	
eritrocitos 1 514 1 4344,	
alta 3 514 3 4340,4739,5227,	
acuosa 1 514 1 4336,	
baja 3 514 3 4334,4869,5179,	
soporte 1 514 1 4329,	
sobredosificación 1 514 1 4310,	
general 1 514 1 4305,	
150 1 514 1 4300,	
ingestión 1 514 1 4298,	
manipulación 1 514 1 6763,	
auricular 1 514 1 4294,	
unión 1 514 1 4341,	
episodio 2 514 2 4291,4742,	
experimentó 1 514 1 4289,	
paciente 3 514 3 4288,4684,6681,	
Un 1 514 1 4287,	
sobredosis 2 514 2 4286,4324,	
Sobredosis 1 514 1 4279,	
meses) 1 514 1 4276,	
nevera 1 514 1 6660,	
36 5 514 5 4275,4676,4803,4843,5516,	
post-transplante 1 514 1 4274,	
mediana 3 514 3 4271,4941,5116,	
60 5 514 5 4270,4806,4891,6714,6807,	
brazo 3 514 3 4263,5277,5358,	
agudo 5 514 5 4255,4745,5063,5258,5315,	
serios 1 514 1 4251,	
ml/min 1 514 1 4239,	
basal 1 514 1 4234,	
filtrado 1 514 1 4232,	
90) 1 514 1 4227,	
subgrupo 4 514 4 4222,5205,5242,5284,	
cesó 1 514 1 4217,	
ng/ml) 1 514 1 4207,	
­ 1 514 1 4205,	
(niveles 1 514 1 4201,	
evalúa 1 514 1 4187,	
marcha 1 514 1 4185,	
SHU/PTT/MAT 1 514 1 4174,	
biliar) 1 514 1 4105,	
ureteral 1 514 1 4104,	
conductos 1 514 1 4102,	
vascular 1 514 1 4099,	
ejemplo 2 514 2 4096,6450,	
(por 2 514 2 4095,6449,	
quirúrgica 1 514 1 4091,	
fascial 1 514 1 4089,	
cirugía 1 514 1 4084,	
anormal 1 514 1 4080,	
proporcionalmente 1 514 1 4068,	
suspensión 1 514 1 4062,	
resolvió 1 514 1 4053,	
inmunosupresoras 1 514 1 4042,	
terapias 1 514 1 4041,	
pulmonar) 1 514 1 4033,	
fibrosis 1 514 1 4032,	
idiopática) 1 514 1 4030,	
(BONO 1 514 1 4029,	
organizativa 1 514 1 4028,	
idiopática 1 514 1 4025,	
obliterante 1 514 1 4024,	
bronquiolitis 1 514 1 4023,	
raramente 1 514 1 4022,	
neumonitis 1 514 1 4020,	
intersticial 2 514 2 4014,4051,	
aparecido 1 514 1 4010,	
Han 1 514 1 4009,	
mortal 1 514 1 4002,	
necrosis 1 514 1 4000,	
raros 2 514 2 3998,6350,	
hepatotoxicidad 1 514 1 3981,	
particular 1 514 1 3968,	
REVISIÓN 1 514 1 6918,	
complementarias 1 514 1 3954,	
etiología 1 514 1 4016,	
Exploraciones 1 514 1 3953,	
lugar 1 514 1 3950,	
generales 2 514 2 3945,4330,	
urinarios 1 514 1 3943,	
renales 2 514 2 3941,5424,	
musculoesqueléticos 1 514 1 3935,	
subcutáneo 1 514 1 3933,	
tejido 2 514 2 3932,3938,	
Erupción 1 514 1 3929,	
Acné 1 514 1 3928,	
mediastínicos 1 514 1 3921,	
glomerular) 1 514 1 5982,	
torácicos 1 514 1 3919,	
respiratorios 2 514 2 3918,4103,	
vasculares 1 514 1 3916,	
cardiacos 1 514 1 3914,	
hepatobiliares 1 514 1 3901,	
Trastornos 12 514 12 3892,3900,3902,3906,3913,3915,3917,3922,3924,3934,3940,3944,	
pólipos) 1 514 1 3891,	
quistes 1 514 1 3889,	
(incl 1 514 1 3888,	
especificadas 1 514 1 3887,	
malignas 1 514 1 3884,	
agitar 1 514 1 6852,	
benignas 1 514 1 3883,	
realizará 1 514 1 6753,	
Neoplasias 1 514 1 3882,	
Linfoma 1 514 1 3880,	
interrumpió 1 514 1 5015,	
Cáncer 1 514 1 3877,	
infestaciones 1 514 1 3875,	
Infecciones 1 514 1 3873,	
1/10 1 514 1 3870,	
000 2 514 2 3867,3871,	
1/1 1 514 1 3866,	
(parámetros 1 514 1 5598,	
experimentaron 1 514 1 4602,	
< 3 514 3 3863,3868,3872,	
1/100 1 514 1 3862,	
( 4 514 4 3859,3861,3865,3869,	
sistemas 1 514 1 3858,	
Raras 1 514 1 3855,	
Frecuentes 1 514 1 3852,	
Muy 1 514 1 3850,	
Clasificación 1 514 1 3848,	
administrando 1 514 1 3840,	
regímenes 1 514 1 3837,	
causal 1 514 1 3823,	
razonable 1 514 1 3820,	
sospecha 2 514 2 3819,4351,	
existe 1 514 1 3815,	
Sólo 1 514 1 3807,	
gravedad 1 514 1 3800,	
decreciente 1 514 1 3798,	
orden 1 514 1 3797,	
comercialización 1 514 1 3790,	
post- 1 514 1 3789,	
realizados 1 514 1 3784,	
últimos 1 514 1 3781,	
frecuencia 3 514 3 3776,3806,5088,	
clasificación 1 514 1 3770,	
enumeran 2 514 2 3795,3809,	
resumen 1 514 1 3762,	
tabla 1 514 1 3760,	
siguiente 1 514 1 3759,	
conforme 2 514 2 3749,3986,	
incrementarse 2 514 2 3748,3985,	
(LDH) 1 514 1 3738,	
deshidrogenasa 1 514 1 3737,	
lactato 1 514 1 3736,	
diarrea 1 514 1 3731,	
artralgia 1 514 1 3729,	
abdominal 1 514 1 3725,	
hipertrigliceridemia 1 514 1 3723,	
incrementada 1 514 1 5274,	
hiperglucemia 1 514 1 3722,	
hipercolesterolemia 1 514 1 3721,	
urinario 1 514 1 3720,	
intolerancia 2 514 2 9581,9591,	
tracto 1 514 1 3719,	
plasmáticas 1 514 1 4347,	
anemia 1 514 1 3714,	
>10% 1 514 1 3707,	
01 1 514 1 5582,	
(ocurren 1 514 1 3705,	
notificadas 1 514 1 3704,	
avance 1 514 1 6275,	
frecuentes 3 514 3 3703,3851,3854,	
Reacciones 1 514 1 3697,	
realizado 1 514 1 3682,	
máquinas 2 514 2 3678,3694,	
utilizar 2 514 2 3677,3693,	
conducir 2 514 2 3675,3691,	
capacidad 2 514 2 3673,3689,	
Efectos 1 514 1 3670,	
(versección 1 514 1 3665,	
interrumpir 2 514 2 3663,4133,	
reversibles 3 514 3 3661,4131,6431,	
esperma 2 514 2 3644,4114,	
alteraciones 3 514 3 3639,3947,4109,	
interrumpida 1 514 1 3632,	
adversas 7 514 7 3625,3698,3701,3765,3793,5078,6194,	
provocar 1 514 1 3623,	
L04A 1 514 1 4379,	
potencial 1 514 1 3619,	
vacuolación 1 514 1 6223,	
humana 2 514 2 3616,5740,	
excreta 1 514 1 3612,	
radioactividad 2 514 2 3602,5771,	
detectó 1 514 1 3601,	
lactantes 2 514 2 3599,3627,	
ratas 7 514 7 3598,6304,6371,6417,6423,6460,6468,	
ulcerosas 1 514 1 6359,	
Después 5 514 5 3590,4780,5387,5751,6639,	
eficaz 1 514 1 3589,	
claramente 1 514 1 3566,	
embarazo 1 514 1 3560,	
humanos 1 514 1 3553,	
jeringa 3 514 3 6719,6767,6789,	
seres 1 514 1 3552,	
Berkshire 1 514 1 6874,	
desconoce 1 514 1 3548,	
utilizarse 3 514 3 3557,3585,6820,	
3) 3 514 3 3546,3667,4138,	
reproductiva 1 514 1 3542,	
toxicidad 2 514 2 3541,6405,	
mostrado 1 514 1 3540,	
estudios 6 514 6 3536,3683,4411,5287,5373,6403,	
embarazadas 1 514 1 3534,	
cutáneas 3 514 3 4898,5173,6358,	
mujeres 1 514 1 3533,	
utilización 1 514 1 3529,	
suficientes 1 514 1 3526,	
existen 1 514 1 3524,	
lactancia 2 514 2 3522,3629,	
Embarazo 1 514 1 3520,	
trimetoprim/sulfametoxazol 1 514 1 3517,	
prednisolona 1 514 1 3515,	
nifedipino 1 514 1 3514,	
metilprednisolona 1 514 1 3513,	
glibenclamida 1 514 1 3512,	
digoxina 1 514 1 3511,	
atorvastatina 1 514 1 3510,	
aciclovir 1 514 1 3509,	
significativas 1 514 1 3500,	
observado 3 514 3 3496,3638,4108,	
metoclopramida 1 514 1 3492,	
cisaprida 1 514 1 3490,	
gastrointestinales 2 514 2 3488,3923,	
polisorbato 1 514 1 6563,	
procinéticos 1 514 1 3487,	
observarse 1 514 1 3482,	
Pueden 1 514 1 3481,	
evitado 1 514 1 3480,	
mediado 2 514 2 3472,5953,	
afecta 2 514 2 3469,5950,	
pomelo 4 514 4 3468,5949,6537,6827,	
intestinales 1 514 1 3458,	
células 7 514 7 3457,4387,4519,6227,6265,6279,6454,	
disminuir 1 514 1 3451,	
gp-P 1 514 1 3449,	
reciben 1 514 1 3441,	
observadas 2 514 2 3437,6196,	
elevadas 1 514 1 3434,	
producir 1 514 1 3428,	
sacarosa 1 514 1 9565,	
desequilibrio 1 514 1 5031,	
necesarias 1 514 1 3426,	
isoenzimas 1 514 1 3419,	
1/10) 2 514 2 3860,3864,	
actividad 2 514 2 3416,5749,	
inhiba 1 514 1 3414,	
vivo 3 514 3 3410,4572,6289,	
espera 1 514 1 3407,	
CYP3A4/5 1 514 1 3404,	
CYP2C19 1 514 1 3401,	
CYP2C9 1 514 1 3400,	
P450 2 514 2 3399,5704,	
microsomal 1 514 1 3398,	
hepático 1 514 1 3397,	
citocromo 2 514 2 3396,5703,	
vitro 2 514 2 3394,6257,	
in 4 514 4 3393,3409,6256,6288,	
fenitoína) 1 514 1 3389,	
fenobarbital 1 514 1 3388,	
anticonvulsivos 1 514 1 3386,	
perforatum) 1 514 1 3385,	
Juan 1 514 1 3383,	
San 1 514 1 3382,	
Hierba 1 514 1 3380,	
proteasa) 1 514 1 3361,	
cimetidina 1 514 1 3357,	
rutas 1 514 1 4483,	
bromocriptina 1 514 1 3356,	
troleandomicina; 1 514 1 3353,	
antibióticos 1 514 1 3352,	
antifúngicos 1 514 1 3349,	
(DEHP) 1 514 1 6575,	
nicardipina; 1 514 1 3347,	
calcio 2 514 2 3346,4409,	
bloqueantes 1 514 1 3341,	
ej 3 514 3 3340,3379,9596,	
(p 3 514 3 3339,3378,9595,	
débiles 1 514 1 3324,	
moderados 1 514 1 3322,	
gastrointestinal 1 514 1 6235,	
(1 2 514 2 5198,6513,	
posibles 1 514 1 3319,	
plazo 1 514 1 3314,	
afectar 1 514 1 3303,	
decidió 1 514 1 4878,	
puedan 1 514 1 3302,	
posibilidad 1 514 1 3295,	
interacciones 4 514 4 3287,3318,3483,3497,	
resultados 4 514 4 3268,3290,5604,7534,	
Aunque 2 514 2 3266,3390,	
linfático 1 514 1 3899,	
etinilestradiol 1 514 1 3265,	
norgestrel/0 1 514 1 3261,	
0 3 514 3 3257,5651,5675,	
significativa 5 514 5 3253,4360,4698,4788,5612,	
(6-120 1 514 1 4997,	
orales 2 514 2 3245,5476,	
específica 1 514 1 4443,	
eritromicina 2 514 2 3165,3213,	
neumopatía 2 514 2 4013,4050,	
Eritromicina 1 514 1 3155,	
medicaciones 2 514 2 3154,3243,	
farmacocinéticas 4 514 4 3288,3484,3498,5386,	
ambas 2 514 2 3153,3242,	
adecuadas 2 514 2 3149,3240,	
crónicas 1 514 1 6360,	
reducciones 4 514 4 3148,3237,6429,6439,	
t 3 514 3 3133,3184,3207,	
S-(-) 1 514 1 3126,	
plasma 3 514 3 3125,3216,5513,	
Tanto 1 514 1 3116,	
fármacos 2 514 2 3094,3181,	
0PH 1 514 1 6876,	
verapamilo 2 514 2 3078,3123,	
Verapamilo 1 514 1 3068,	
desmetildiltiazem 1 514 1 3047,	
desacetildiltiazem 1 514 1 3045,	
metabolitos 2 514 2 3044,5725,	
envase 2 514 2 6601,6706,	
aumentaron 8 514 8 3024,3106,3127,3194,3217,6069,6115,6355,	
pacientes) 1 514 1 3710,	
tmáx 1 514 1 3021,	
acné 1 514 1 3730,	
diltiazem 3 514 3 3010,3040,3051,	
120 2 514 2 3007,6844,	
simultánea 2 514 2 2997,5439,	
marzo 2 514 2 6901,6911,	
11 3 514 3 2974,5653,5992,	
incrementa 2 514 2 2963,3988,	
días) 1 514 1 2959,	
n=226) 1 514 1 5661,	
(400 1 514 1 2944,	
múltiples 3 514 3 2939,3075,3162,	
(una 1 514 1 2929,	
Voriconazol 1 514 1 2917,	
9 3 514 3 2901,4278,6886,	
4; 2 514 2 2896,3026,	
Tmáx 1 514 1 2889,	
refleja 1 514 1 2880,	
(inhibidor 5 514 5 2853,2918,2991,3069,3156,	
Ketoconazol 1 514 1 2852,	
co- 1 514 1 2842,	
pesos 1 514 1 6442,	
71 1 514 1 2835,	
deseados 1 514 1 4202,	
% 14 514 14 2832,2836,5448,5746,5873,5905,5971,5974,6072,6076,6087,6118,6122,6133,	
82 1 514 1 2831,	
Cmáx 4 514 4 2828,2888,3020,5943,	
chino 1 514 1 6270,	
Diltiazem 1 514 1 2990,	
redujo 4 514 4 2789,2823,6084,6130,	
tenían 2 514 2 4618,4626,	
repetidas 4 514 4 2786,2860,5429,5477,	
(inductor 1 514 1 2779,	
administrar 2 514 2 2769,6592,	
afectó 5 514 5 2760,2863,3011,3036,3083,	
sanos 7 514 7 2751,2962,5411,5760,5850,6093,6142,	
policloruro 1 514 1 6579,	
voluntarios 3 514 3 2750,5759,5849,	
Una 1 514 1 2743,	
Medicamentos 1 514 1 6938,	
afectadas 1 514 1 2742,	
administró 1 514 1 2722,	
tmax 3 514 3 2719,3097,5579,	
Cmax 8 514 8 2716,2733,2965,3096,3118,3183,3205,5571,	
Reino 1 514 1 6877,	
incrementos 1 514 1 2713,	
reflejó 1 514 1 2710,	
respectivamente 10 514 10 2702,2837,2903,2976,3033,3115,3203,3226,6077,6123,	
listados 1 514 1 4313,	
80% 1 514 1 2701,	
141% 1 514 1 2699,	
183% 1 514 1 2698,	
AUC 13 514 13 2694,2736,2825,2891,2968,3023,3100,3121,3188,3211,5945,6063,6109,	
produjeron 1 514 1 2690,	
10 6 514 6 2679,2803,2900,2999,4361,6914,	
2h 1 514 1 2672,	
normativas 1 514 1 6758,	
(300 3 514 3 2665,2676,2688,	
simultáneamente 2 514 2 2662,2752,	
administrados 3 514 3 2661,2671,7522,	
A 6 514 6 2655,4671,4690,4889,5165,6056,	
incrementados 1 514 1 2651,	
grado 4 514 4 2643,2869,3089,3176,	
tasa 11 514 11 2641,2867,3086,3173,4230,4246,4736,4793,5170,5979,6569,	
Rifampicina 1 514 1 2778,	
CYP3A4) 7 514 7 2639,2781,2855,2920,2993,3071,3158,	
(sustrato 1 514 1 2637,	
Ciclosporina 1 514 1 2636,	
4) 7 514 7 2635,2851,2916,2989,3975,5150,5349,	
testículos 2 514 2 6233,6445,	
incrementan 3 514 3 2591,2605,3751,	
motivo 2 514 2 5959,6585,	
disminuyen 2 514 2 2585,2611,	
afectan 1 514 1 2569,	
consecución 1 514 1 6159,	
sustancias 3 514 3 2567,3355,3508,	
proteína 1 514 1 4441,	
influenciadas 1 514 1 2564,	
posterior 2 514 2 2558,4081,	
delgado 1 514 1 2552,	
intestino 1 514 1 2551,	
excluir 1 514 1 3293,	
situada 1 514 1 2548,	
P 2 514 2 2546,5710,	
preparación 1 514 1 6648,	
glicoproteína 2 514 2 2545,5709,	
multifármaco 1 514 1 2544,	
flujo 2 514 2 2543,3453,	
bomba 1 514 1 2541,	
sustrato 2 514 2 2538,5701,	
isoenzima 1 514 1 2532,	
intestinal 1 514 1 2525,	
eu 1 514 1 6944,	
metabolizado 1 514 1 2521,	
sacarasa 1 514 1 9577,	
medicamentos 2 514 2 2512,9603,	
Interacción 1 514 1 2508,	
asociados 4 514 4 2500,4175,6486,9554,	
(SHU/PTT/MAT) 2 514 2 2499,9553,	
microangiopatía 2 514 2 2497,9551,	
trombótica 4 514 4 2495,2498,9549,9552,	
urémico 2 514 2 2491,9545,	
hemolítico 2 514 2 2490,9544,	
síndrome 2 514 2 2489,9543,	
Incompatibilidades 1 514 1 6528,	
2% 3 514 3 2438,4778,9492,	
final 1 514 1 5466,	
nefrótico) 3 514 3 2435,5160,9489,	
(síndrome 3 514 3 2434,5159,9488,	
nefrosis 3 514 3 2433,5158,9487,	
aparición 3 514 3 2431,5156,9485,	
notificó 3 514 3 2428,5153,9482,	
común 2 514 2 2401,9455,	
rasgo 2 514 2 2400,9454,	
observó 4 514 4 2398,3248,6410,9452,	
calcineurina 17 514 17 2387,2463,2483,2505,4168,4180,4198,4987,5142,5197,5253,5336,5368,9441,9517,9537,9559,	
conversión 10 514 10 2382,2419,2459,4194,4981,5097,5184,9436,9473,9513,	
evaluación 2 514 2 2379,9433,	
estudio 11 514 11 2377,2443,3271,4183,4952,4967,5209,6421,6464,9431,9497,	
urinarias 5 514 5 2374,2409,5271,9428,9463,	
proteínas 8 514 8 2373,2408,2572,4346,5219,5270,9427,9462,	
excreción 6 514 6 2371,2406,5217,5268,9425,9460,	
periódico 2 514 2 2368,9422,	
cuantitativo 2 514 2 2367,9421,	
control 2 514 2 2366,9420,	
realizar 2 514 2 2364,9418,	
recuperación 3 514 3 2357,4153,9411,	
dolor 1 514 1 3724,	
retrasar 3 514 3 2355,4151,9409,	
continuada 2 514 2 2333,9387,	
coadministración 2 514 2 2332,9386,	
recomendarse 3 514 3 2330,7112,9384,	
seguían 2 514 2 2325,9379,	
neoplasia 2 514 2 2318,9372,	
Poco 1 514 1 3853,	
incidencia 4 514 4 2316,3742,4894,9370,	
así 3 514 3 2310,4862,9364,	
altas 4 514 4 2305,5318,5325,9359,	
éxito 2 514 2 2292,9346,	
excluyendo 1 514 1 4729,	
retiró 3 514 3 2290,4597,9344,	
controles 2 514 2 2281,9335,	
absorbe 1 514 1 5397,	
comparación 10 514 10 2270,2320,4717,4914,5327,6027,6089,6135,9324,9374,	
calculada 7 514 7 2268,2309,4798,4963,5224,9322,9363,	
glomerular 6 514 6 2267,2308,4233,4796,9321,9362,	
filtración 6 514 6 2266,2307,4795,5981,9320,9361,	
bajas 2 514 2 2264,9318,	
tasas 8 514 8 2262,2303,5060,5255,5312,5320,9316,9357,	
altos 3 514 3 2257,5126,9311,	
TITULAR 1 514 1 6860,	
tuvieron 5 514 5 2254,2295,5311,9308,9349,	
tratados 8 514 8 2241,2274,3648,4118,5297,5331,9295,9328,	
precaución 2 514 2 2238,9292,	
tenerse 2 514 2 2237,9291,	
perjudicial 2 514 2 2231,9285,	
usarse 2 514 2 6650,6770,	
conocidos 2 514 2 2226,9280,	
coadministran 2 514 2 2223,9277,	
sérica 7 514 7 2211,2260,2301,4621,9265,9314,9355,	
creatinina 7 514 7 2210,2259,2300,4620,9264,9313,9354,	
formas 1 514 1 2515,	
Producto 2 514 2 2186,9240,	
Características 2 514 2 2184,9238,	
Resúmenes 2 514 2 2181,9235,	
respectivos 2 514 2 2180,9234,	
descritos 2 514 2 2177,9231,	
media 3 514 3 4790,5113,5455,	
anticonceptivo 3 514 3 3281,3307,3588,	
adversos 5 514 5 2176,3746,4250,4308,9230,	
efectos 9 514 9 2175,3658,3686,3745,4128,4249,4307,4415,9229,	
rabdomiólisis 2 514 2 2172,9226,	
fibrato 2 514 2 2162,9216,	
(hidroxi-metil-glutaril)- 1 514 1 2157,	
HMG 2 514 2 2156,9212,	
inhibidor 7 514 7 2153,2480,4165,5334,5366,9209,9534,	
administra 3 514 3 2151,3050,9207,	
les 3 514 3 2150,4924,9206,	
tolerada 2 514 2 2138,9194,	
fibratos 2 514 2 2134,9190,	
reductasa 4 514 4 2132,2159,9188,9214,	
(Hypericum 1 514 1 3384,	
CoA 3 514 3 2131,2158,9187,	
HMG- 2 514 2 2130,9186,	
continuar 2 514 2 2112,9168,	
reevaluarse 2 514 2 2108,9164,	
refractaria 2 514 2 2106,9162,	
riesgo/beneficio 4 514 4 2097,2110,9153,9166,	
iniciar 2 514 2 2088,9144,	
establecida 2 514 2 2085,9141,	
lípidos 2 514 2 2080,9136,	
reductores 2 514 2 2078,9134,	
(EMEA) 1 514 1 6939,	
ejercicio 2 514 2 2075,9131,	
dieta 2 514 2 2074,9130,	
adoptarse 2 514 2 2071,9127,	
detectase 2 514 2 2068,9124,	
tests 2 514 2 2062,9117,	
hiperlipidemia 8 514 8 2060,2069,2084,2105,9115,9125,9140,9161,	
monitorizados 6 514 6 2056,2165,3144,3233,9111,9219,	
reciban 2 514 2 2052,9107,	
requerir 2 514 2 2047,9102,	
colesterol 2 514 2 2041,9096,	
séricos 2 514 2 2039,9094,	
(CYP3A4) 1 514 1 5706,	
reclutamiento 2 514 2 4219,5017,	
mg) 4 514 4 2666,2677,2689,2934,	
CMV 2 514 2 2019,9074,	
enfermedad 2 514 2 2017,9072,	
especialmente 2 514 2 2010,9065,	
(CMV) 2 514 2 2002,9057,	
citomegalovirus 2 514 2 2001,9056,	
	5 1 514 1 4368,	
max 3 514 3 3134,3185,3208,	
carinii 4 514 4 1974,1988,9029,9043,	
Pneumocystis 4 514 4 1973,1987,9028,9042,	
neumonía 6 514 6 1971,1984,4027,4253,9026,9039,	
antimicrobiana 4 514 4 1965,1981,9020,9036,	
medios 3 514 3 5633,6061,6107,	
protección 2 514 2 1957,9012,	
factor 2 514 2 1955,9010,	
protectoras 2 514 2 1949,9004,	
prendas 2 514 2 1948,9003,	
fibrilación 1 514 1 4293,	
usando 2 514 2 1947,9002,	
sujetos 5 514 5 2961,4882,5410,6092,6141,	
UV 2 514 2 1946,9001,	
luz 5 514 5 1940,1945,6676,8995,9000,	
global 1 514 1 5058,	
exposición 5 514 5 1937,2874,5908,6207,8992,	
cáncer 2 514 2 1931,8986,	
4% 1 514 1 4930,	
padecer 2 514 2 1930,8985,	
(CsA) 1 514 1 2656,	
Como 2 514 2 1919,8974,	
angioneurótico 2 514 2 1918,8973,	
tipo 3 514 3 1915,6711,8970,	
radiomarcado 1 514 1 3596,	
desencadenado 2 514 2 1912,8967,	
angiotensina) 2 514 2 1910,8965,	
convertidora 2 514 2 1908,8963,	
enzima 2 514 2 1907,8962,	
(inhibidores 2 514 2 1904,8959,	
IECA 2 514 2 1903,8958,	
raras 2 514 2 1895,8950,	
vasculitis 2 514 2 1887,8942,	
dermatitis 2 514 2 1884,8939,	
angioedema 2 514 2 1883,8938,	
anafilácticas/anafilactoides 2 514 2 1882,8937,	
incluían 1 514 1 4044,	
hipersensibilidad 4 514 4 1879,1889,8934,8944,	
leve 1 514 1 6050,	
reacciones 14 514 14 1877,1881,1913,3624,3700,3764,3792,3811,4524,5077,6193,8932,8936,8968,	
asociado 4 514 4 1871,2032,8926,9087,	
inmunosupresor 4 514 4 1860,2091,8915,9147,	
parte 3 514 3 1856,5765,8911,	
fructosa 1 514 1 9584,	
resultando 2 514 2 1845,8900,	
bronquial 2 514 2 1844,8899,	
vieron 2 514 2 2649,2741,	
anastomosis 2 514 2 1843,8898,	
significativos 2 514 2 1825,8880,	
celular 1 514 1 4472,	
hemodinámicamente 2 514 2 1824,8879,	
túbulos) 1 514 1 6458,	
derrames 2 514 2 1823,8878,	
(incluyendo 4 514 4 1822,4019,4727,8877,	
pleural 2 514 2 1818,8873,	
	Prospectos 1 514 1 9601,	
derrame 4 514 4 1817,1820,8872,8875,	
linfedema 2 514 2 1816,8871,	
periférico 3 514 3 1815,3728,8870,	
acumulación 2 514 2 1810,8865,	
También 5 514 5 1804,2426,5151,8859,9480,	
anómala 2 514 2 1801,8856,	
post-aleatorización 1 514 1 4769,	
placebo 2 514 2 2278,9332,	
presentarmayor 1 514 1 1798,	
kg/m2 2 514 2 1796,8849,	
pericárdico 2 514 2 1821,8876,	
30 5 514 5 1795,5970,6622,6721,8848,	
superior 2 514 2 1793,8846,	
IMC 2 514 2 1792,8845,	
médica 2 514 2 1787,8840,	
hernia 1 514 1 4090,	
bibliografía 2 514 2 1786,8839,	
Basándose 3 514 3 1780,4331,8833,	
dehiscencia 6 514 6 1777,1840,4088,4093,8830,8895,	
linfocele 3 514 3 1775,3726,8828,	
heridas 7 514 7 1768,1779,1803,4098,8821,8832,8858,	
cicatrización 5 514 5 1766,1800,4079,8819,8855,	
casos 17 514 17 1759,1808,1838,1969,3656,3979,3997,4011,4048,4077,4126,4322,6348,8812,8863,8893,9024,	
notificado 12 514 12 1758,1807,1837,1968,2923,3978,3996,4076,8811,8862,8892,9023,	
muerte 6 514 6 1755,4260,5068,5263,5322,8808,	
injerto 12 514 12 1752,2352,4148,4258,4646,4681,4703,4856,5066,5261,8805,9406,	
Anticonceptivos 1 514 1 3244,	
pérdida 7 514 7 1750,4256,4644,4731,5064,5259,8803,	
desembocando 2 514 2 1745,8798,	
(HAT) 2 514 2 1744,8797,	
33 1 514 1 6086,	
controlar 2 514 2 2167,9221,	
arteria 2 514 2 1742,8795,	
trombosis 2 514 2 1739,8792,	
incremento 7 514 7 1737,2035,2403,2692,8790,9090,9457,	
tacrolimus 3 514 3 1732,4426,8785,	
están 3 514 3 1711,4416,8764,	
pulmón 4 514 4 1703,1868,8756,8923,	
hígado 5 514 5 1701,1724,2529,8754,8777,	
inmunosupresora 3 514 3 1694,5750,8747,	
establecido 4 514 4 1685,2452,8738,9506,	
sepsis 2 514 2 1681,8734,	
	6 1 514 1 6498,	
mortales 5 514 5 1678,1849,4037,8731,8904,	
oportunistas 2 514 2 1675,8728,	
infección 2 514 2 1671,8724,	
aumentar 5 514 5 1666,3332,3367,3460,8719,	
inmune 3 514 3 1663,4529,8716,	
sistema 5 514 5 1662,3898,3904,4528,8715,	
excesiva 2 514 2 1660,8713,	
significativamente 13 514 13 2650,2864,3012,3084,3171,4737,4809,4867,4900,4949,5124,5177,5316,	
supresión 2 514 2 1659,8712,	
triglicéridos 2 514 2 2044,9099,	
8) 6 514 6 1657,1893,5040,5164,8710,8948,	
inmunosupresión 8 514 8 1653,2220,3839,3956,4506,6368,8706,9274,	
piel 8 514 8 1646,1933,3879,3927,3971,4939,8699,8988,	
particularmente 2 514 2 1643,8696,	
tumores 4 514 4 1642,3966,6333,8695,	
desarrollo 5 514 5 1636,2170,3961,8689,9224,	
infecciones 7 514 7 1632,1674,1677,3717,8685,8727,8730,	
susceptibilidad 5 514 5 1630,1668,3959,8683,8721,	
diálisis 2 514 2 4616,5967,	
rifabutina) 3 514 3 1623,2604,8676,	
rifampicina 6 514 6 1622,2602,2788,2812,2847,8675,	
claritromicina) 3 514 3 1617,2584,8670,	
itraconazol 3 514 3 1614,2581,8667,	
ketoconazol 5 514 5 1612,2579,2862,2912,8665,	
FARMACOLÓGICAS 1 514 1 4364,	
(tales 6 514 6 1610,1620,2577,2600,8663,8673,	
trombocitopénica 2 514 2 2494,9548,	
potentes 3 514 3 1607,2625,8660,	
co-administración 6 514 6 1602,2620,2908,2926,2981,8655,	
macho) 1 514 1 6321,	
estables 3 514 3 1590,5425,8643,	
alcancen 2 514 2 1588,8641,	
prolongado 2 514 2 1582,8635,	
hipocalemia 1 514 1 3715,	
periodo 3 514 3 1581,5620,8634,	
volumen 1 514 1 6840,	
prolonga 2 514 2 1560,8613,	
Dado 3 514 3 1554,3617,8607,	
reducción 10 514 10 1530,1543,2313,4056,5870,5976,6478,8582,8595,9367,	
SL6 1 514 1 6875,	
atenuadas 2 514 2 1498,8549,	
vacunas 2 514 2 1497,8548,	
evitar 2 514 2 1493,8544,	
efectiva 3 514 3 1490,5488,8541,	
incluyendo 13 514 13 1483,1672,1774,1880,2092,4087,4252,5727,8534,8725,8827,8935,9148,	
Durante 7 514 7 1478,2139,2190,3568,8529,9195,9244,	
vacunación 4 514 4 1477,1486,8528,8537,	
respuesta 3 514 3 1474,6382,8525,	
variar 2 514 2 1472,8523,	
novo 8 514 8 1464,1720,1866,5296,5364,8514,8773,8921,	
marco 2 514 2 1459,8509,	
Ac) 2 514 2 1453,8503,	
CYP2D6 1 514 1 3402,	
(IL-2R 2 514 2 1452,8502,	
bajos 2 514 2 2298,9352,	
IL-2 4 514 4 1451,5310,5345,8501,	
receptor 4 514 4 1449,5308,5343,8499,	
frente 2 514 2 1447,8497,	
posteriores 4 514 4 1432,2416,8482,9470,	
obtenida 2 514 2 1428,8478,	
extensamente 3 514 3 1416,2520,8466,	
Sirolimus 11 514 11 1411,2518,2534,3034,4073,4381,5699,5711,5732,6245,8461,	
citotóxicos 2 514 2 1410,8460,	
anticuerpos 4 514 4 1409,1446,8459,8496,	
mofetil 6 514 6 1406,1438,5010,5301,8456,8488,	
micofenolato 6 514 6 1405,1437,5009,5300,8455,8487,	
azatioprina 5 514 5 1404,2283,5011,8454,9337,	
púrpura 2 514 2 2493,9547,	
administrado 2 514 2 1397,8447,	
inmunosupresores 13 514 13 1390,1422,1470,1482,3847,4375,4430,5007,6342,8440,8472,8521,8533,	
agentes 19 514 19 1389,1402,1421,2077,2189,2225,3348,3486,3846,4374,4429,5006,6341,8439,8452,8471,9133,9243,9279,	
concomitante 12 514 12 1386,1899,2123,2193,2475,4160,5004,8436,8954,9179,9247,9529,	
estratificado 1 514 1 4957,	
alto 5 514 5 1377,2014,5854,8427,9069,	
adecuadamente 2 514 2 1372,8422,	
estudiado 4 514 4 1371,1415,8421,8465,	
(24 1 514 1 6698,	
especiales 5 514 5 1364,6553,6655,6728,8414,	
precauciones 2 514 2 1363,8413,	
Advertencias 2 514 2 1361,8411,	
activo 3 514 3 1352,3413,8402,	
principio 3 514 3 1351,3412,8401,	
Hipersensibilidad 2 514 2 1349,8399,	
material 1 514 1 6803,	
Contraindicaciones 2 514 2 1348,8398,	
5) 4 514 4 1345,1627,8395,8680,	
interaccionar 2 514 2 1339,8389,	
exfoliativa 2 514 2 1885,8940,	
productos 2 514 2 1333,8383,	
(microemulsión) 4 514 4 1330,2766,2777,8380,	
consideraciones 2 514 2 1325,8375,	
Otras 3 514 3 1324,3317,8374,	
acuerdo 4 514 4 1310,3778,6755,8360,	
realizarse 2 514 2 1308,8358,	
equivalentes 3 514 3 1300,5938,8350,	
elevado 3 514 3 1958,4642,9013,	
convertidas 2 514 2 1298,8348,	
desconocida 1 514 1 4018,	
sido 5 514 5 1297,3660,4130,6345,8347,	
utilizando 4 514 4 1292,2061,8342,9116,	
medidas 5 514 5 1291,2072,4327,8341,9128,	
ficha 2 514 2 1288,8338,	
indican 2 514 2 1285,8335,	
Todas 2 514 2 1278,8328,	
medicinales 4 514 4 1334,1337,8384,8387,	
relaciona 2 514 2 1269,8319,	
fabricante 2 514 2 1267,8317,	
referencia 4 514 4 1262,1277,8312,8327,	
registrado 2 514 2 1257,8307,	
inmunoensayo 2 514 2 1256,8306,	
método 5 514 5 1254,1274,3587,8304,8324,	
solar 4 514 4 1941,1953,8996,9008,	
use 2 514 2 1252,8302,	
Cuando 5 514 5 1250,2221,2720,8300,9275,	
intercambiables 2 514 2 1249,8299,	
técnicas 2 514 2 1246,8296,	
mediante 3 514 3 1244,4396,8294,	
animales 3 514 3 3538,4508,6203,	
obtenidos 5 514 5 1243,5535,5834,6139,8293,	
inmunoensayos 2 514 2 1238,8288,	
Agencia 1 514 1 6935,	
mide 2 514 2 1231,8281,	
clínica 3 514 3 1223,6400,8273,	
práctica 2 514 2 1222,8272,	
medir 2 514 2 1212,8262,	
utilizado 5 514 5 1206,1853,6739,8256,8908,	
dosificaciones 1 514 1 7911,	
sugiere 2 514 2 3283,4434,	
han 27 514 27 1205,1296,1757,1806,1836,1870,1967,2451,3495,3539,3637,3659,3681,3977,3995,4075,4107,4129,6344,8255,8346,8810,8861,8891,8925,9022,9505,	
cromatográficos 8 514 8 1203,1235,1294,1301,8253,8285,8344,8351,	
Hubo 3 514 3 4244,4734,6032,	
métodos 8 514 8 1202,1208,1234,1293,8252,8258,8284,8343,	
basan 2 514 2 1200,8250,	
24 8 514 8 1195,2414,4674,4802,5145,6628,8245,9468,	
recomendados 4 514 4 1189,1712,8239,8765,	
intervalos 3 514 3 1188,5986,8238,	
semivida 6 514 6 1186,1562,5465,5487,8236,8615,	
prolongación 3 514 3 1183,6145,8233,	
produce 3 514 3 1180,6154,8230,	
estacionario 3 514 3 1177,6162,8227,	
Período 1 514 1 6615,	
alimentos 1 514 1 5919,	
alcanzar 3 514 3 1174,5894,8224,	
retraso 8 514 8 1172,1763,2347,4143,6156,8222,8816,9401,	
estable 4 514 4 1169,5473,5499,8219,	
muestren 2 514 2 1166,8216,	
7 8 514 8 1158,2972,3224,3669,5506,5647,6859,8208,	
medirse 2 514 2 1150,8200,	
la(s) 2 514 2 1128,8178,	
Las 8 514 8 1112,3699,3791,5059,5076,5254,6192,8162,	
24% 1 514 1 3137,	
deberá 1 514 1 1107,	
adición 2 514 2 1097,8146,	
debido 5 514 5 1094,1170,5028,8143,8220,	
mL/min 5 514 5 4969,5027,5050,5111,5214,	
excede 2 514 2 1090,8139,	
estimada 2 514 2 1089,8138,	
40 6 514 6 1083,1092,4238,5585,8132,8141,	
exceder 2 514 2 1081,8130,	
(PVC) 1 514 1 6582,	
diaria 4 514 4 1078,1088,8127,8137,	
máxima 2 514 2 1075,8124,	
mantenimiento- 2 514 2 1068,8117,	
(nueva 2 514 2 1065,8114,	
03 1 514 1 3262,	
3x 2 514 2 1064,8113,	
retirada 2 514 2 4634,4926,	
Dosis 2 514 2 1058,8107,	
considerablemente 2 514 2 1052,8101,	
incrementar 5 514 5 1051,2485,4170,8100,9539,	
carga 14 514 14 1047,1060,1102,1106,1131,1148,1567,8096,8109,8151,8155,8181,8198,8620,	
(287 1 514 1 6030,	
considerarse 8 514 8 1043,2095,2213,3147,3236,8092,9151,9267,	
Además 3 514 3 1035,4575,8084,	
actual) 4 514 4 1034,1072,8083,8121,	
disminuyó 1 514 1 3135,	
deseada/concentración 2 514 2 1032,8082,	
(concentración 2 514 2 1031,8081,	
actual 4 514 4 1029,1224,8079,8274,	
nueva 7 514 7 1023,1038,2430,5155,8073,8087,9484,	
proporción 2 514 2 1021,8071,	
simple 2 514 2 1020,8070,	
ciclosporina) 2 514 2 1007,8057,	
(tras 2 514 2 1002,8052,	
(gp-P) 1 514 1 2547,	
adicionales 2 514 2 998,8048,	
requieren 2 514 2 996,8046,	
mediados 1 514 1 4417,	
Si 6 514 6 989,1085,3048,6677,8039,8134,	
eliminación 13 514 13 985,2559,4556,4657,4713,4753,4820,4874,6555,6730,6735,6765,8035,	
corresponder 2 514 2 980,8030,	
aumenta 6 514 6 974,3957,4067,5460,6567,8024,	
velocidad 4 514 4 969,983,8019,8033,	
consecuencia 1 514 1 5081,	
inmunosupresiva 2 514 2 959,8009,	
aumento 6 514 6 955,3733,5885,5902,6307,8005,	
limitarse 2 514 2 1935,8990,	
veces) 4 514 4 952,967,8002,8017,	
(incremento 4 514 4 949,964,7999,8014,	
interacción 5 514 5 947,2517,3250,3273,7997,	
ausencia 4 514 4 945,961,7995,8011,	
mayor 10 514 10 939,1629,1927,4247,5764,6010,7989,8682,8852,8982,	
veces 12 514 12 938,2821,2902,2975,3032,3114,3130,3202,3225,5463,5889,7988,	
necesitará 2 514 2 935,7985,	
recibían 3 514 3 1772,5543,8825,	
medio 3 514 3 930,6002,7980,	
término 2 514 2 929,7979,	
Por 6 514 6 928,1975,2553,6583,7978,9030,	
incremente 2 514 2 923,7973,	
multicéntrico 1 514 1 4954,	
interrumpa 2 514 2 918,7968,	
zumo 8 514 8 3466,5928,5947,6535,6548,6812,6825,6849,	
descenderán 2 514 2 913,7963,	
consiguiente 2 514 2 908,7958,	
metabolismo 9 514 9 903,2587,2607,3330,3369,3471,3908,5952,7952,	
inhibe 5 514 5 901,3392,4382,4451,7950,	
Tras 3 514 3 877,5449,7926,	
anterior 2 514 2 876,7867,	
cambio 5 514 5 873,1570,7864,7904,8623,	
hepatocelular 1 514 1 6317,	
aumentos 1 514 1 2883,	
días 10 514 10 868,1111,1125,1159,5507,6623,7859,8161,8175,8209,	
obtenido 2 514 2 864,7855,	
nivel 4 514 4 862,3990,4070,7853,	
único 2 514 2 861,7852,	
basarse 4 514 4 856,1017,7847,8067,	
deben 23 514 23 855,1118,1149,1307,1573,2054,2070,2163,3052,3142,3146,3231,3235,4325,6819,7846,8168,8199,8357,8626,9109,9126,9217,	
ajustes 8 514 8 849,997,1015,1303,7840,8047,8065,8353,	
manera 4 514 4 846,2101,7837,9157,	
jeringas 2 514 2 6626,6722,	
De 4 514 4 845,2098,7836,9154,	
leche 2 514 2 3605,3615,	
alimento 2 514 2 840,7831,	
consecuentemente 2 514 2 836,7827,	
nutrición 1 514 1 3912,	
relación 4 514 4 822,3822,5509,7813,	
tomarse 2 514 2 817,7808,	
consecutivos 2 514 2 1165,8215,	
variabilidad 3 514 3 814,6035,7805,	
minimizar 2 514 2 812,7803,	
laboratorio 4 514 4 810,2064,7801,9119,	
parámetros 7 514 7 808,3642,4112,5531,5617,6164,7799,	
CL/F/W 1 514 1 5593,	
solubilidad 1 514 1 4335,	
tisulares 2 514 2 806,7797,	
biopsias 2 514 2 805,7796,	
(FG) 1 514 1 4797,	
aumentó 2 514 2 2813,3170,	
signos/síntomas 2 514 2 803,7794,	
prestar 2 514 2 797,7788,	
ajustar 2 514 2 790,7781,	
base 8 514 8 788,1424,3214,4835,4959,7779,7887,8474,	
única 7 514 7 787,2745,2801,2930,3276,5755,7778,	
especial 4 514 4 777,799,7768,7790,	
necesidad 4 514 4 773,958,7764,8008,	
telitromicina 3 514 3 1615,2582,8668,	
tengan 2 514 2 772,7763,	
mTOR 1 514 1 4476,	
probable 2 514 2 768,7759,	
elimina 2 514 2 763,7754,	
notablemente 2 514 2 760,7751,	
carbamazepina 1 514 1 3387,	
reduce 2 514 2 759,7750,	
) 9 514 9 1384,2448,5883,5899,6612,8434,8519,8606,9502,	
(3) 2 514 2 752,7743,	
C) 3 514 3 6104,6638,6666,	
y/o 9 514 9 751,2133,2161,5717,6446,6606,7742,9189,9215,	
5); 2 514 2 750,7741,	
interrupción 7 514 7 746,879,1004,3581,7737,7928,8054,	
conjuntamente 4 514 4 741,1398,7732,8448,	
administran 2 514 2 740,7731,	
CYP3A4 13 514 13 738,1609,2533,2576,2599,2627,2631,3326,3365,3474,5955,7729,8662,	
inhibidores 23 514 23 736,1606,2127,2385,2461,2502,2574,2624,3321,3359,3447,4177,4196,4985,5140,5194,5250,7727,8659,9183,9439,9515,9556,	
inductores 7 514 7 734,1619,2597,2629,3363,7725,8672,	
(2) 2 514 2 732,7723,	
historial 1 514 1 9573,	
hepática; 2 514 2 731,7722,	
presentaninsuficiencia 1 514 1 730,	
(1) 2 514 2 726,7716,	
poblaciones 5 514 5 725,771,6172,7715,7762,	
siguientes 12 514 12 724,1401,1993,2007,3507,3578,4846,6222,7714,8451,9048,9062,	
extracción 1 514 1 6571,	
estrechamente 2 514 2 714,7704,	
Deben 2 514 2 712,7702,	
monitorización 4 514 4 701,779,7691,7770,	
óptima 4 514 4 698,847,7688,7838,	
cromatográfico) 4 514 4 695,898,7685,7947,	
ensayo 15 514 15 694,1210,1313,4552,5565,5606,5641,5659,5683,6260,6273,6287,7684,8260,8363,	
valores 13 514 13 692,1240,1271,2886,3018,5657,5681,6060,6106,6138,7682,8290,8321,	
(expresado 2 514 2 690,7680,	
objetivo 7 514 7 684,889,1306,7674,7924,7938,8356,	
aparentemente 2 514 2 2136,9192,	
concentraciones 16 514 16 674,1054,1113,1280,1320,1589,2791,3423,5494,5816,7664,8103,8163,8330,8370,8642,	
horas 15 514 15 668,827,1196,2684,2724,2756,2772,2948,2956,5419,5547,6629,7658,7818,8246,	
recibieron 10 514 10 662,1833,1963,4565,4816,5413,5427,7652,8888,9018,	
mayoría 10 514 10 657,1010,1747,3653,3830,4123,4392,7647,8060,8800,	
danazol 1 514 1 3358,	
fármaco 7 514 7 655,707,782,3278,7645,7697,7773,	
modificar 2 514 2 645,7635,	
necesario 7 514 7 644,1050,3063,3567,6679,7634,8099,	
cuidadosamente 4 514 4 628,1512,7619,8564,	
controlado 1 514 1 4956,	
monitorizar 6 514 6 627,1119,1511,7618,8169,8563,	
aproximadamente 7 514 7 619,2696,2818,2829,5445,5461,7610,	
mitad 4 514 4 618,1538,7609,8590,	
reducir 4 514 4 609,3328,3371,7600,	
primera 1 514 1 6897,	
grave 7 514 7 606,1137,1526,6100,7597,8187,8578,	
función 20 514 20 595,1540,2201,2234,2350,2360,3767,4146,4156,4628,4860,5052,5351,6174,7586,8592,9255,9288,9404,9414,	
alteración 4 514 4 592,1761,7583,8814,	
pared 1 514 1 2524,	
reducido 2 514 2 588,7579,	
diferencia 5 514 5 2758,4696,4782,4851,5611,	
aclaramiento 5 514 5 583,1545,2815,7574,8597,	
hepática 21 514 21 581,596,605,624,1136,1508,1525,1743,4001,6049,6099,6153,6241,7572,7587,7596,7615,8186,8560,8577,8796,	
ajuste 7 514 7 568,1140,2215,3065,7559,8190,9269,	
ningún 3 514 3 567,6801,7558,	
(fosfatidilcolina 1 514 1 6508,	
requiere 4 514 4 566,699,7557,7689,	
insuficiencia 18 514 18 562,580,604,623,1135,1507,1524,6048,6098,6152,7553,7571,7595,7614,7721,8185,8559,8576,	
822) 3 514 3 557,5840,7517,	
= 9 514 9 556,1027,1063,4226,4269,5839,7516,8077,8112,	
(n 5 514 5 555,4225,4268,5838,7515,	
adulta 3 514 3 548,5837,7508,	
producida 2 514 2 1985,9040,	
población 3 514 3 547,5836,7507,	
similares 8 514 8 542,5070,5265,5831,6169,6208,7502,7535,	
hipofosfatemia 1 514 1 3716,	
35 4 514 4 532,5821,5904,7492,	
jóvenes 3 514 3 524,5812,7484,	
rápidamente 1 514 1 5398,	
diferente 4 514 4 520,4421,5807,7480,	
responder 4 514 4 517,941,7477,7991,	
clotrimazol 1 514 1 3350,	
podrían 2 514 2 516,7476,	
determinar 5 514 5 513,1318,5803,7473,8368,	
años 17 514 17 511,540,554,5075,5168,5233,5801,5826,5845,5993,5999,6619,7471,7500,7514,7532,7548,	
hidroxidesmetil 1 514 1 5731,	
65 11 514 11 510,539,553,5800,5825,5844,7470,7499,7513,7531,7547,	
> 6 514 6 508,537,5798,5823,7468,7497,	
canales 1 514 1 3344,	
número 4 514 4 504,4651,5794,7464,	
incluyeron 4 514 4 502,4577,5792,7462,	
clínicos 18 514 18 498,804,1393,1431,1716,2120,3783,4537,5288,5788,6199,6211,7456,7795,8443,8481,8769,9176,	
ensayos 15 514 15 497,1392,1430,1715,2119,3782,4655,5787,6198,6250,7455,8442,8480,8768,9175,	
Los 37 514 37 496,525,1187,1239,1302,1469,2049,2239,2284,2573,2596,3017,3138,3227,3320,3362,3446,3535,4637,5530,5630,5786,5813,6163,6361,7454,7485,7518,7868,8237,8289,8352,8520,9104,9293,9338,9560,	
(>65 2 514 2 494,7452,	
avanzada 2 514 2 493,7451,	
edad 6 514 6 492,5847,5988,6016,6044,7450,	
2) 13 514 13 487,575,600,844,1553,1597,5697,7445,7566,7591,7835,8605,8650,	
apartado 41 514 41 485,573,598,748,842,1343,1381,1466,1625,1655,1891,2423,2445,2633,2849,2914,2987,3544,3973,4136,4241,5038,5148,5162,5347,5695,6609,6644,7443,7564,7589,7739,7833,8393,8431,8516,8678,8708,8946,9477,9499,	
limitada 4 514 4 481,4284,6401,7439,	
disponible 3 514 3 479,6928,7437,	
farmacocinética 8 514 8 478,948,2762,3038,3251,3300,7436,7998,	
recomendar 2 514 2 467,7425,	
experiencia 4 514 4 465,3788,4283,7423,	
suficiente 6 514 6 464,505,4652,5795,7422,7465,	
hay 4 514 4 463,3286,4281,7421,	
No 25 514 25 462,564,642,1598,1682,2328,2449,2616,2838,2904,2977,3246,3493,3523,3606,3679,5608,7092,7420,7555,7632,8651,8735,9382,9503,	
años) 4 514 4 461,495,7419,7453,	
riesgode 1 514 1 1799,	
18 8 514 8 460,551,5842,5998,7418,7511,7545,8555,	
(< 2 514 2 459,7417,	
adolescentes 4 514 4 458,475,7416,7433,	
bloqueo 2 514 2 4398,4480,	
niños 8 514 8 456,473,483,1827,7414,7431,7441,8882,	
específicas 3 514 3 442,4484,7400,	
recomendaciones 2 514 2 441,7399,	
trombocitopenia 1 514 1 3713,	
permitir 2 514 2 440,7398,	
limitados 2 514 2 438,7396,	
seguridad 10 514 10 435,1687,2454,4189,4976,5036,6191,7393,8740,9508,	
datos 9 514 9 431,526,1783,3525,4840,5814,7389,7486,8836,	
Actualmente 3 514 3 429,4280,7387,	
observa 2 514 2 419,7377,	
eficacia 11 514 11 416,433,1689,2456,3305,4191,4978,7374,7391,8742,9510,	
elevados 5 514 5 409,2208,4008,7367,9262,	
fluconazol; 1 514 1 3351,	
requieran 2 514 2 402,7361,	
(predominantemente 2 514 2 400,7359,	
transplante 23 514 23 395,535,1461,1699,1722,1864,2009,2028,2395,4086,4214,5471,5828,7322,7354,7495,7527,8511,8752,8775,8919,9064,9083,	
indique 2 514 2 390,7349,	
escasa 2 514 2 387,7346,	
Hay 2 514 2 386,7345,	
usos 2 514 2 1709,8762,	
negra 8 514 8 385,399,428,453,7344,7358,7386,7411,	
raza 8 514 8 384,398,427,452,7343,7357,7385,7410,	
receptores 9 514 9 382,393,450,1718,4578,7341,7352,7408,8771,	
alternativo 2 514 2 379,7338,	
inmunosupresivo 2 514 2 378,7337,	
justificar 1 514 1 4632,	
e 8 514 8 374,1902,2590,3874,4406,5730,7333,8957,	
clínicamente 4 514 4 370,3252,3499,7329,	
apropiado 4 514 4 369,2216,7328,9270,	
resulte 2 514 2 368,7327,	
mayoritario 1 514 1 5736,	
intentarse 2 514 2 346,7305,	
resultado 6 514 6 342,1650,4490,4504,7301,8703,	
da 3 514 3 341,4502,7300,	
abandono 2 514 2 335,7294,	
En 63 514 63 328,364,601,620,1132,1220,1391,1423,1504,1521,1713,1894,1959,2081,2117,2203,2343,2375,3651,3757,4046,4121,4139,4181,4304,4319,4507,4834,5041,5102,5203,5285,5369,5719,5848,5962,6045,6095,6353,6370,6402,6419,6467,6624,7287,7323,7592,7611,8182,8270,8441,8473,8556,8573,8766,8949,9014,9137,9173,9257,9397,9429,9568,	
administrarse 5 514 5 325,1108,1978,7284,9033,	
ajustarse 2 514 2 303,7262,	
semanas 5 514 5 296,3577,6426,7255,7901,	
8 9 514 9 295,2447,2958,3696,3876,4318,6879,7254,9501,	
equivalente) 2 514 2 280,7239,	
vs 3 514 3 4776,4931,4970,	
técnica 4 514 4 279,1289,7238,8339,	
delfármaco) 1 514 1 7631,	
o 61 514 61 278,338,343,735,761,838,869,1123,1143,1295,1335,1353,1568,1616,1618,1702,1731,1753,1762,2076,2279,2583,2603,2628,2753,3041,4060,4573,4624,5917,6057,6284,6538,6547,6795,6811,6848,7105,7237,7297,7302,7726,7752,7829,7860,7908,8173,8193,8345,8385,8403,8621,8669,8671,8755,8784,8806,8815,9132,9333,9598,	
naranja 4 514 4 5930,6550,6814,6851,	
anastomótica 1 514 1 4094,	
monoclonal 2 514 2 277,7236,	
150-400 2 514 2 274,7233,	
son 11 514 11 272,425,436,1248,3431,3711,4311,7231,7383,7394,8298,	
primeros 3 514 3 267,5092,7226,	
2- 2 514 2 265,7224,	
concentración 22 514 22 259,528,704,1168,1192,1214,1226,1242,5404,5454,5876,5896,7218,7488,7694,7896,7918,8218,8242,8264,8276,8292,	
edema 5 514 5 1814,1917,3727,8869,8972,	
sugerido 2 514 2 257,7216,	
intervalo 10 514 10 256,683,888,1305,3804,7215,7673,7923,7937,8355,	
esteroides 2 514 2 251,7210,	
disminución 3 514 3 249,6412,7208,	
régimen 9 514 9 247,377,1859,2218,4668,7206,7336,8914,9272,	
fármaco) 5 514 5 238,322,641,7197,7281,	
cambios 2 514 2 3297,6362,	
terapéutica 12 514 12 236,320,639,653,705,780,7195,7279,7630,7643,7695,7771,	
Monitorización 8 514 8 235,319,638,652,7194,7278,7629,7642,	
cromatográfico 6 514 6 233,317,1275,7192,7276,8325,	
(ensayo 8 514 8 232,276,316,897,7191,7235,7275,7946,	
ng/ml 14 514 14 231,275,315,689,896,5578,5649,5673,5678,7190,7234,7274,7679,7945,	
12 21 514 21 230,312,688,893,1991,2947,2955,3576,4204,4673,4772,4801,5573,5698,5996,7189,7271,7524,7678,7942,9046,	
total 23 514 23 226,310,636,680,721,1217,1229,1520,2796,3105,3193,5638,5721,5739,5909,7185,7269,7627,7670,7711,8267,8279,8572,	
sangre 31 514 31 225,309,635,679,720,1216,1228,1519,2795,3059,3104,3192,3336,3375,3740,3895,5457,5511,5529,5637,5720,5738,5881,7184,7268,7626,7669,7710,8266,8278,8571,	
valle 36 514 36 223,260,307,406,631,675,863,891,1055,1114,1164,1193,1321,1515,3754,3991,4005,4071,5632,5817,7182,7219,7266,7365,7622,7665,7854,7897,7919,7940,8104,8164,8214,8243,8371,8567,	
niveles 41 514 41 222,306,405,630,716,910,1152,1163,1514,1576,2038,2207,2255,2296,2593,2613,3055,3139,3228,3334,3373,3462,3753,4004,5631,6205,6389,7181,7265,7364,7621,7706,7960,8202,8213,8566,8629,9093,9261,9309,9350,	
obtener 4 514 4 221,305,7180,7264,	
monitorizarse 7 514 7 713,1574,2199,3053,7703,8627,9253,	
individualizarse 2 514 2 218,7177,	
día 5 514 5 212,2951,5669,5693,7171,	
vez 4 514 4 210,6834,6858,7169,	
seguida 2 514 2 205,7164,	
después 26 514 26 202,269,361,669,743,828,865,1126,2673,2685,2773,2797,4295,5094,5502,5553,5627,7161,7228,7320,7659,7734,7819,7856,7902,8176,	
inhibición 3 514 3 3430,4474,4494,	
posible 7 514 7 201,1635,2169,6214,7160,8688,9223,	
sea 6 514 6 200,1049,3565,6545,7159,8098,	
pronto 2 514 2 198,7157,	
administrada 4 514 4 196,2748,7155,8158,	
inducción 6 514 6 191,649,1444,7150,7639,8494,	
dosis 79 514 79 189,214,299,403,571,611,647,755,832,925,932,976,1001,1024,1028,1039,1045,1066,1069,1074,1087,1100,1104,1129,1142,1146,1533,1565,1572,2744,2785,2800,2859,2931,2940,3067,3076,3151,3163,3239,3275,3442,4059,5414,5428,5475,5555,5664,5688,5754,7148,7173,7258,7362,7562,7602,7637,7746,7823,7975,7982,8026,8051,8074,8078,8088,8094,8115,8118,8123,8136,8149,8153,8179,8192,8196,8585,8618,8625,	
infecciosa 1 514 1 4017,	
usual 4 514 4 184,1921,7143,8976,	
dosificación 9 514 9 183,776,852,875,5379,7142,7767,7843,7866,	
pauta 3 514 3 181,5377,7140,	
La 55 514 55 180,213,239,284,476,656,696,778,899,968,1022,1073,1328,1628,1658,2640,2782,2811,2856,2994,3072,3095,3159,3182,3204,3741,3829,3955,4431,4473,4593,4789,5350,5430,5464,5508,6144,6734,6766,6921,7139,7172,7198,7243,7434,7646,7686,7769,7948,8018,8072,8122,8378,8681,8711,	
post-transplante) 2 514 2 179,7138,	
(2 3 514 3 175,5781,7134,	
asoció 2 514 2 1734,8787,	
inicial 2 514 2 174,7133,	
Terapia 4 514 4 173,281,7132,7240,	
Uso 14 514 14 170,380,454,488,558,576,1385,7129,7339,7412,7446,7549,7567,8435,	
trasplantes 2 514 2 169,7128,	
cualificado 2 514 2 167,7126,	
apropiadamente 2 514 2 166,7125,	
especialista 2 514 2 165,7124,	
dirección 2 514 2 162,7121,	
iniciarse 5 514 5 157,375,4326,7116,7334,	
debe 54 514 54 156,217,243,286,302,324,354,371,784,796,816,979,1042,1080,1260,1492,1934,1977,2094,2107,2198,2212,2236,3478,3556,3584,3630,5960,6531,6649,6769,7115,7176,7202,7245,7261,7283,7313,7330,7775,7787,7807,8029,8091,8129,8310,8543,8989,9032,9150,9163,9252,9266,9290,	
tratamiento 25 514 25 155,1480,1501,2048,2090,2114,3311,3570,3635,3826,4265,4670,4722,4829,4983,5083,5099,5279,5360,7114,8531,8552,9103,9146,9170,	
El 18 514 18 154,255,582,2020,2473,2703,3465,4065,4158,4489,5002,5925,5946,7113,7214,7573,9075,9527,	
exclusivamente 2 514 2 150,7088,	
efecto 4 514 4 2230,2704,4512,9284,	
x 2 514 2 1030,8080,	
administración 24 514 24 147,1874,1898,2122,2192,2728,2783,2843,2857,2937,2995,3073,3160,3593,3952,5390,5438,5451,6607,7085,8929,8953,9178,9246,	
forma 6 514 6 145,519,5057,5808,7083,7479,	
adultos) 2 514 2 1829,8884,	
Posología 2 514 2 143,7081,	
1) 6 514 6 140,1468,2425,4243,7078,9479,	
5 43 514 43 139,486,574,599,843,867,1156,1382,1467,1552,1596,2160,2424,2507,2657,2667,2819,2820,3129,3545,3666,4137,4242,4362,5383,5504,5690,5888,5990,6186,6701,7077,7444,7565,7590,7834,7858,8206,8432,8517,8604,8649,9478,	
desmetil 1 514 1 5729,	
secciones 6 514 6 135,1548,1592,7073,8600,8645,	
(ver 49 514 49 134,484,572,597,637,747,841,1342,1380,1465,1546,1591,1624,1654,1890,2422,2444,2632,2848,2913,2986,3543,3972,4135,4240,5037,5147,5161,5346,5694,6608,6643,7071,7442,7563,7588,7628,7738,7832,8392,8430,8515,8598,8644,8677,8707,8945,9476,9498,	
62 1 514 1 5480,	
20 5 514 5 314,895,4206,7273,7944,	
progresivamente 4 514 4 133,288,7070,7247,	
sólo 2 514 2 126,7063,	
mantenimiento 23 514 23 123,283,613,994,1041,1071,1535,2342,2393,2469,4210,4762,4993,7060,7242,7604,8044,8090,8120,8587,9396,9447,9523,	
biodisponibilidad 3 514 3 3014,5862,7097,	
terapia 18 514 18 121,240,697,792,882,992,1693,2141,2340,7058,7199,7687,7783,7931,8042,8746,9197,9394,	
mantenerse 6 514 6 119,159,355,7056,7118,7314,	
meses 27 514 27 116,178,268,360,1992,2006,2253,2415,4589,4677,4693,4773,4807,4844,4892,4998,5093,5146,5626,7053,7137,7227,7319,9047,9061,9307,9469,	
período 8 514 8 111,291,2248,4768,6695,7048,7250,9302,	
durante 28 514 28 109,289,356,990,1499,1579,1989,2003,2246,2949,2957,3309,3558,3574,3633,4585,4766,5089,5618,7046,7248,7315,8040,8550,8632,9044,9058,9300,	
corticosteroides 14 514 14 108,125,327,1407,1440,5013,5303,5338,5552,7045,7062,7286,8457,8490,	
microemulsión 7 514 7 106,130,254,5545,7043,7067,7213,	
ciclosporina 73 514 73 105,129,253,262,285,337,350,672,757,825,834,884,900,916,963,988,1329,1403,1730,2197,2243,2276,2294,2327,2335,2654,2664,2675,2687,2707,2731,2765,2776,4425,4594,4636,4715,4726,4756,4765,4822,4833,4876,4888,4912,4928,5441,5544,7042,7066,7212,7221,7244,7296,7309,7662,7748,7816,7825,7933,7949,7966,8013,8038,8379,8453,8783,9251,9297,9330,9348,9381,9389,	
combinación 10 514 10 103,348,1418,1442,3843,5436,7040,7307,8468,8492,	
inicialmente 2 514 2 101,7038,	
utilice 5 514 5 100,1316,6599,7037,8366,	
indica 1 514 1 5517,	
recomienda 27 514 27 96,608,626,886,1456,1510,1528,1600,1997,2363,2618,2768,2840,2906,2979,5912,7033,7599,7617,7893,7935,8506,8562,8580,8653,9052,9417,	
Se 32 514 32 95,795,1204,1491,1756,1835,1869,1996,2362,2767,2921,3547,3636,3976,3994,4074,4106,4538,5014,5867,5911,6437,7032,7786,7892,8254,8542,8809,8890,8924,9051,9416,	
lactosa 1 514 1 9567,	
renal 36 514 36 94,396,536,563,1462,2029,2202,2235,2361,2396,2472,4157,4215,4568,4629,4861,4996,5053,5294,5352,5472,5541,5829,6175,7031,7355,7496,7528,7554,8512,9084,9256,9289,9415,9450,9526,	
trasplante 17 514 17 93,204,271,363,1995,2471,4592,4995,5293,5540,5629,7030,7163,7230,9050,9449,9525,	
sometidos 9 514 9 90,1697,2026,3835,5965,6183,7027,8750,9081,	
inmunológico 7 514 7 89,1379,3905,4545,4641,7026,8429,	
riesgo 17 514 17 88,1378,1928,2015,2487,3550,3983,4066,4172,4544,4640,7025,8428,8853,8983,9070,9541,	
moderado 3 514 3 87,4549,7024,	
presentan 12 514 12 83,1376,1926,2206,2346,4142,7020,7720,8426,8981,9260,9400,	
normales 2 514 2 6094,6143,	
adultos 6 514 6 81,172,6029,7018,7131,7541,	
pacientes 130 514 130 80,330,366,422,490,507,523,533,560,578,590,602,621,660,711,728,1013,1133,1374,1505,1522,1558,1696,1770,1789,1831,1862,1924,1960,2012,2025,2050,2082,2103,2145,2204,2240,2273,2285,2323,2344,2391,2441,2467,3439,3647,3833,4039,4117,4140,4212,4224,4540,4563,4600,4638,4814,4825,4907,4920,4991,5022,5045,5106,5207,5235,5245,5291,5330,5421,5469,5538,5797,5811,5822,5963,6012,6021,6046,6096,6150,6352,7017,7289,7325,7380,7448,7467,7483,7493,7525,7540,7551,7569,7581,7593,7612,7650,7701,7718,7869,8063,8183,8424,8557,8574,8611,8749,8823,8842,8886,8917,8979,9015,9067,9080,9105,9138,9159,9201,9258,9294,9327,9339,9377,9398,9445,9495,9521,9570,	
órganos 4 514 4 78,3772,3856,7015,	
rechazo 9 514 9 76,4254,4533,4605,4744,5062,5257,5314,7013,	
profilaxis 8 514 8 74,1964,1980,1998,7011,9019,9035,9053,	
indicado 2 514 2 71,7008,	
está 4 514 4 70,6927,7007,7920,	
Rapamune 125 514 125 69,98,117,148,186,216,242,301,323,352,373,500,615,651,666,815,854,1026,1062,1077,1367,1436,1484,1503,1691,1773,1834,1854,2023,2053,2093,2116,2125,2143,2195,2245,2338,2389,2421,2465,2477,2770,2810,3005,3316,3445,3554,3572,3650,3664,3828,3841,4045,4064,4120,4134,4303,4349,4353,4560,4661,4709,4724,4817,4831,4886,4989,5101,5133,5186,5238,5281,5299,5362,5561,5790,5914,5936,6529,6559,6594,6777,6786,7006,7035,7054,7086,7145,7175,7201,7260,7282,7311,7332,7458,7521,7606,7641,7656,7806,7845,8076,8111,8126,8417,8486,8535,8554,8744,8826,8889,8909,9078,9108,9149,9172,9181,9199,9249,9299,9392,9443,9475,9519,9531,	
terapéuticas 3 514 3 68,3443,7005,	
pantalla 2 514 2 1952,9007,	
Indicaciones 2 514 2 67,7004,	
/ 5 514 5 2492,2496,3881,9546,9550,	
	4 2 514 2 65,7002,	
CLÍNICOS 2 514 2 64,7001,	
DATOS 3 514 3 63,6496,7000,	
fluidos 2 514 2 1812,8867,	
4 70 514 70 62,136,141,228,293,667,686,749,826,937,1124,1344,1346,1359,1360,1549,1593,1626,1656,1892,2446,2506,2634,2683,2755,2771,2850,2895,2898,2915,2988,3195,3196,3198,3200,3518,3668,3695,3974,4277,4317,4777,5039,5149,5163,5348,5696,6493,6653,6999,7074,7079,7187,7252,7657,7676,7740,7817,7987,8174,8394,8396,8409,8410,8601,8646,8679,8709,8947,9500,	
Huntercombe 1 514 1 6869,	
	Solución 1 514 1 60,	
FARMACÉUTICA 2 514 2 59,6980,	
FORMA 2 514 2 58,6979,	
debidos 1 514 1 6336,	
3 33 514 33 57,115,177,266,359,1033,1122,1162,1347,2005,2252,3028,3108,3221,3258,4554,4611,4932,5462,5581,5887,6187,6614,6978,7052,7136,7225,7318,8172,8212,8397,9060,9306,	
6 28 514 28 55,194,2412,2809,3031,3219,3519,4588,5091,5201,5576,5625,6494,6495,6526,6557,6558,6610,6611,6613,6645,6652,6700,6725,6726,6976,7153,9466,	
sección 5 514 5 54,4316,6492,6556,6975,	
mostraron 2 514 2 4848,6305,	
ver 6 514 6 53,234,318,6974,7193,7277,	
excipientes 5 514 5 52,1358,6502,6973,8408,	
completa 2 514 2 50,6971,	
lista 2 514 2 49,6970,	
abreviada 1 514 1 5380,	
linfoma 4 514 4 1638,3963,6281,8691,	
afroamericanos) 2 514 2 401,7360,	
consultar 2 514 2 47,6968,	
Para 6 514 6 46,811,4935,6815,6967,7802,	
Excipientes 2 514 2 45,6966,	
optimizarse 2 514 2 244,7203,	
sirolimus 124 514 124 44,411,447,471,530,585,633,677,718,794,905,912,927,934,978,1057,1116,1154,1198,1219,1282,1323,1341,1394,1517,1604,1728,1876,1901,2353,2561,2589,2595,2609,2615,2622,2647,2660,2670,2682,2738,2747,2793,2817,2845,2876,2893,2910,2928,2970,2983,3016,3057,3080,3102,3141,3167,3190,3230,3255,3338,3377,3391,3425,3455,3464,3502,3531,3595,3610,3621,3756,3993,4007,4149,4162,4200,4267,4436,4509,5395,5434,5459,5519,5534,5635,5819,5864,5879,6068,6114,6167,6469,6965,7369,7405,7429,7490,7576,7624,7667,7708,7785,7954,7962,7977,7984,8028,8106,8166,8204,8248,8269,8332,8373,8391,8444,8569,8657,8781,8931,8956,9407,9563,	
mg 29 514 29 42,195,208,664,1084,1093,2658,2668,2680,2804,2945,2953,3000,3008,3259,3263,4301,5559,5667,5691,6951,6963,7154,7167,7654,7889,7891,8133,8142,	
contiene 3 514 3 40,6562,6961,	
ml 3 514 3 39,6715,6808,	
	Cada 2 514 2 38,6959,	
CUANTITATIVA 2 514 2 37,6958,	
Y 2 514 2 36,6957,	
CUALITATIVA 2 514 2 35,6956,	
COMPOSICIÓN 2 514 2 34,6955,	
2 46 514 46 33,113,137,142,207,407,663,951,966,1110,1550,1594,2723,2933,3107,3112,3113,3201,5074,5167,5232,5286,5384,5418,5558,5574,5577,5584,5648,5666,5782,6516,6527,6618,6954,7050,7075,7080,7166,7653,7900,8001,8016,8160,8602,8647,	
conjuntivo 1 514 1 3939,	
oral 20 514 20 32,61,153,192,2807,2943,2996,3003,3082,3169,3282,3308,5394,5866,6561,6596,7091,7151,7460,7879,	
solución 11 514 11 31,2806,3002,3081,3168,5393,5562,6560,6595,7459,7878,	
mg/ml 1 514 1 30,	
	Rapamune 2 514 2 28,6949,	
MEDICAMENTO 3 514 3 27,4367,6948,	
interrumpirse 6 514 6 132,287,372,7069,7246,7331,	
NOMBRE 2 514 2 25,6946,	
atención 2 514 2 800,7791,	
1 34 514 34 23,24,29,41,56,66,1383,2897,2950,3025,3027,3030,3109,3110,3128,3197,3218,3220,3223,4369,5072,5230,5407,5767,6499,6945,6950,6962,6977,6996,7003,7898,8433,8518,	
PRODUCTO 1 514 1 22,	
DEL 4 514 4 21,26,6919,6947,	
grupo 11 514 11 4707,4720,4751,4760,4827,4872,4884,5129,5182,5190,6042,	
CARACTERÍSTICAS 1 514 1 20,	
LAS 1 514 1 19,	
DE 9 514 9 18,4365,6861,6864,6881,6883,6888,6892,6916,	
RESUMEN 1 514 1 17,	
O 1 514 1 16,	
absorción 5 514 5 2556,2645,2871,3091,3178,	
TÉCNICA 1 514 1 15,	
voriconazol 5 514 5 1613,2580,2942,2985,8666,	
FICHA 1 514 1 14,	
ocasiones 2 514 2 1896,8951,	
tuvo 2 514 2 673,7663,	
información 10 514 10 11,388,477,1265,1427,6922,7347,7435,8315,8477,	
Toda 1 514 1 9,	
medicamento 6 514 6 8,13,1578,6737,6926,8631,	
Basica 1 514 1 6,	
	Información 1 514 1 5,	
comprimido 1 514 1 6960,	
RECB 1 514 1 4,	
COMP 1 514 1 3,	
100 2 514 2 2,2952,	
2MG 1 514 1 1,	
RAPAMUNE 1 514 1 0,	
